Evidence map›Paper›PMID 25337209›Full record

ArticleInternational journal of clinical and experimental pathology2014

microRNA-423-3p promotes tumor progression via modulation of AdipoR2 in laryngeal carcinoma.

Guofang Guan, Dejun Zhang, Ying Zheng, Lianji Wen, Duojiao Yu, Yanqing Lu, Yan Zhao

Open access · greenAbstract read
In one paragraph

Article in International journal of clinical and experimental pathology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 2 pooled it
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 2 syntheses or guidelines pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Influence of Micro-RNA-423 Gene Variation on Risk and Characteristics of Breast Cancer.Asian Pacific journal of cancer prevention : APJCP · 2022
    Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Differential expression of angiogenesis-related miRNAs andArchives of medical science : AMS · 2020
    Article
  15. Overexpression of Adiponectin Receptors in Opium Users with and without Cancer.Clinical pharmacology : advances and applications · 2020
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Guofang GuanDepartment of Otolaryngology, Head and Neck Surgery, The Second Hospital of Jilin University Changchun 130041, P. R. China.
Dejun ZhangDepartment of Otolaryngology, Head and Neck Surgery, The Second Hospital of Jilin University Changchun 130041, P. R. China.
Ying ZhengDepartment of Otolaryngology, Head and Neck Surgery, Tumor Hospital of Jilin Province Changchun 130012, P. R. China.
Lianji WenDepartment of Otolaryngology, Head and Neck Surgery, The Second Hospital of Jilin University Changchun 130041, P. R. China.
Duojiao YuDepartment of Otolaryngology, Head and Neck Surgery, The Second Hospital of Jilin University Changchun 130041, P. R. China.
Yanqing LuDepartment of Otolaryngology, Head and Neck Surgery, The Second Hospital of Jilin University Changchun 130041, P. R. China.
Yan ZhaoDepartment of Otolaryngology, Head and Neck Surgery, The Second Hospital of Jilin University Changchun 130041, P. R. China.
Second Affiliated Hospital of Jilin University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite of the variety of combined modality treatments for laryngeal carcinoma have been introduced, the distance recurrence rate and 5-year overall survival rate over the past decades are still the major issues, underlining the importance to better understand the biological bases that contribute to disease progression. Here, we reported that miR-423-3p overexpressed in primary laryngeal carcinoma cell line where it plays a critical role in tumor progression. Suppression of miR-423-3p expression resulted in decreasing cell proliferation, clonogenicity, cell migration and invasion. By using in silico prediction algorithms for target identification, AdipoR2 (adiponectin receptor 2) and DUSP4 (MAP kinase phosphatase 2) were identified to be potential targets of miR-423-3p. Overexpression of miR-423-3p was associated with epigenetic silencing of AdipoR2 in human laryngeal carcinoma samples, which have been previously implicated in suppression of tumor proliferation and angiogenesis. Luciferase reporter assays and western blot further confirmed the direct interaction of miR-423-3p with AdipoR2. Our findings have demonstrated that miR-423-3p plays an important oncogenic role in laryngeal carcinoma progression, and further suggest that suppression of miR-423-3p expression might be useful for its clinical management.

Indexed as

3' Untranslated RegionsAlgorithmsBinding SitesCarcinomaCell Line, TumorCell MovementCell ProliferationComputational BiologyComputer SimulationDatabases, GeneticEpigenesis, GeneticGene Expression Regulation, NeoplasticGene SilencingHumansLaryngeal NeoplasmsMicroRNAs3' Untranslated RegionsADIPOR2 protein, humanMicroRNAsMIRN423 microRNA, humanReceptors, AdiponectinLaryngeal carcinomamicroRNAtarget identification

Identifiers

PMID25337209
PMCPMC4203180
OpenAlexW2253183496

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.